Global Medical Data Infrastructure for AI Systems with MedSyntra - Life Sciences Today Podcast Ep 52

Why It Matters

Medentra’s data‑infrastructure removes barriers to AI‑driven healthcare research, giving pharma, AI firms, and governments rapid, compliant access to high‑quality imaging data that can speed drug development and improve patient outcomes.

Key Takeaways

• Medentra normalizes and de‑identifies imaging data for AI research.
• Provides vendor‑neutral archiving, ensuring interoperable, AI‑ready datasets across modalities.
• Connects hospitals to global research groups within hours, enabling rapid collaboration.
• Serves pharma, AI firms, and governments while respecting national data sovereignty.
• Client base growing fast, adding four to six new customers monthly.

Summary

The Life Sciences Today podcast introduced Medentra, a Tel‑Aviv‑based startup building a global infrastructure that transforms fragmented radiology and imaging data into AI‑ready assets for research and clinical use.

Medentra’s platform normalizes DICOM files, strips proprietary tags, and fully de‑identifies patient information while preserving longitudinal links via a common key. The service offers vendor‑neutral archiving and can be deployed on a client’s own infrastructure or in cloud environments (Azure, AWS, Google) that respect each country’s data‑sovereignty rules.

Co‑founders Kristoff Katilla and Avien explain that their LLM‑driven pipeline extracts precise disease descriptors from complex radiology reports, enabling rapid indexing of scans. They cite recent collaborations, such as supplying data for a tuberculosis‑screening model across India, South Africa, and Eastern Europe, and participation in Saudi Arabia’s Vision 2030 biotech accelerator.

By unlocking previously siloed imaging data, Medentra accelerates AI model training, supports pharmaceutical trial analytics, and empowers national health systems to develop population‑level insights, positioning the company as a critical enabler in the emerging med‑tech data economy.

Original Description

We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Asta Ratkeviciene, Co‑Founder and CEO at MedSyntra. In this episode of Life Sciences Today, I talk with Ratkeviciene about building a global, ethically sourced medical imaging data infrastructure across radiology, pathology, oncology, and women’s healthcare. Ratkeviciene explains how MedSyntra aggregates and de-identifies millions of imaging studies, provides a highly curated data marketplace and platform for institutions that require data sovereignty, and partners with clinical experts for annotation and external teams for model development. They discuss why imaging is the core focus, how population differences can degrade AI performance across geographies, MedSyntra’s evolving business model, and the biggest anti‑patterns Ratkeviciene sees in the medical AI ecosystem today.

For more great episodes of our Life Sciences Today Podcast, check out: https://www.healthcareittoday.com/category/life-sciences-today-podcasts/

5PKYAWS38JUSQKJQ